Effectiveness and Safety of Different Doses of BI 1026706 in Patients With Postoperative Dental Pain (a Single-centre, Partially Double-blinded, Randomised, placebo-and Active Comparator-controlled, Single-dose, Parallel-group Study)
Phase of Trial: Phase I
Latest Information Update: 13 Apr 2019
Price : $35 *
At a glance
- Drugs BI 1026706 (Primary) ; Celecoxib
- Indications Dental pain; Postoperative pain
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 05 Nov 2014 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 03 Sep 2014 Planned End Date changed from 1 Sep 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov record.
- 03 Sep 2014 Planned primary completion date changed from 1 Sep 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov record.